Trials that use: Odds ratio
New to this method? Read the tutorial →
4,551 results
- Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hand-carried Ultrasound to Assess Hydronephrosis: Complete Statistical AnalysisIndependent statistical analysis of Hand-carried Ultrasound to Assess Hydronephrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03774719).
- Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: Complete Statistical AnalysisIndependent statistical analysis of Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Haplo/CordIndependent statistical analysis of Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells: Complete Statistical AnalysisIndependent statistical analysis of Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01050764).
- Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery: Complete Statistical AnalysisIndependent statistical analysis of Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00819260).
- HARMONIZE GLIndependent statistical analysis of A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HARPIndependent statistical analysis of Home Hazard Removal Program to Reduce Falls: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02392013).
- HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02232243).
- HCVIndependent statistical analysis of An Integrated Care Model for Improving Hepatitis C Virus Patient Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01849588).
- HCW9218 in Select Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of HCW9218 in Select Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05322408).
- HD-LIPTIndependent statistical analysis of High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HDIL2/EmendIndependent statistical analysis of Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms: Complete Statistical AnalysisIndependent statistical analysis of HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HEAL-LAAIndependent statistical analysis of HEAL-LAA Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05809596).
- Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic: Complete Statistical AnalysisIndependent statistical analysis of Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia: Complete Statistical AnalysisIndependent statistical analysis of Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Health Literacy Interventions to Overcome Disparities in CRC Screening: Complete Statistical AnalysisIndependent statistical analysis of Health Literacy Interventions to Overcome Disparities in CRC Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02360605).
- Healthy Body, Healthy Bones After Bariatric Surgery Trial: Complete Statistical AnalysisIndependent statistical analysis of Healthy Body, Healthy Bones After Bariatric Surgery Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04279392).
- Healthy Volunteer Short Chain Fatty Acid Study: Complete Statistical AnalysisIndependent statistical analysis of Healthy Volunteer Short Chain Fatty Acid Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05254340).
- Healthy, Immunized Communities Study: Complete Statistical AnalysisIndependent statistical analysis of Healthy, Immunized Communities Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03854734).
- Heart Failure Medication Adherence: Complete Statistical AnalysisIndependent statistical analysis of Heart Failure Medication Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03402750).
- HEART-FIDIndependent statistical analysis of Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Helius in Hypertension-I: The UK Hypertension Registry: Complete Statistical AnalysisIndependent statistical analysis of Helius in Hypertension-I: The UK Hypertension Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02553512).
- HELPS-HDIndependent statistical analysis of Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine: Complete Statistical AnalysisIndependent statistical analysis of Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine: primary endpoint results, effect estimate…
- Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure: Complete Statistical AnalysisIndependent statistical analysis of Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01405742).
- Hepatic Effects of Gastric Bypass Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hepatic Effects of Gastric Bypass Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00701376).
- Hepatitis B Booster Study in Adolescence: Complete Statistical AnalysisIndependent statistical analysis of Hepatitis B Booster Study in Adolescence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02169674).
- Heritability of Opioid Effects: A Twin Study: Complete Statistical AnalysisIndependent statistical analysis of Heritability of Opioid Effects: A Twin Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00672438).
- HEROIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HEROES-DCBIndependent statistical analysis of Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hestia2Independent statistical analysis of A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease: primary endpoint results, effect estimate with…
- hFLCTxIndependent statistical analysis of Human Fetal Liver Cell Transplantation in Chronic Liver Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01013194).
- HFSCSIndependent statistical analysis of High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HH4Independent statistical analysis of Post-Discharge Smoking Cessation Strategies: Helping HAND 4: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03603496).
- HHHFA in COPD Patients, With Chronic Bronchitis: Complete Statistical AnalysisIndependent statistical analysis of HHHFA in COPD Patients, With Chronic Bronchitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03959982).
- Hidradenitis Suppurativa Phase 2b Study of Izokibep: Complete Statistical AnalysisIndependent statistical analysis of Hidradenitis Suppurativa Phase 2b Study of Izokibep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05355805).
- Hidradenitis Suppurativa Wound Care: Complete Statistical AnalysisIndependent statistical analysis of Hidradenitis Suppurativa Wound Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04354012).
- High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin’s Lymphoma or Central Nervous System (CNS) Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population: Complete Statistical AnalysisIndependent statistical analysis of High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer: Complete Statistical AnalysisIndependent statistical analysis of High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High Dose or High Dose Frequency Study of Alglucosidase Alfa: Complete Statistical AnalysisIndependent statistical analysis of High Dose or High Dose Frequency Study of Alglucosidase Alfa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483379).
- High Dose Oxytocin Nasal Spray for Treatment of Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of High Dose Oxytocin Nasal Spray for Treatment of Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210310).
- High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: Complete Statistical AnalysisIndependent statistical analysis of High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: Complete Statistical AnalysisIndependent statistical analysis of High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00774046).
- High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size…
- High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00349778).